Metastatic Cancer Synthetic Cohort
Fully synthetic oncology data product focused on metastatic cancer for model development, analytics, evaluation and controlled research workflows.
Technical overview
Designed for
Oncology analytics, model development, treatment/outcome research workflows, benchmark and evaluation development
Before commitment
Synthetic data only. Product scope, schema, calibration references, intended use and commercial licence are confirmed during evaluation. Not a substitute for real clinical evidence.
What a qualified evaluation covers
Confirm intended use, target cohort or domain, format, scale and acceptance criteria.
Review representative samples or product materials where evaluation access is available.
Confirm provenance, permitted use, de-identification or generation position and delivery restrictions as applicable.
Lock deliverables, licence or service terms, milestones, acceptance criteria and transfer method.